KE3841A - An antibiotic compound,a method for its preparation,and compositions containing it - Google Patents

An antibiotic compound,a method for its preparation,and compositions containing it

Info

Publication number
KE3841A
KE3841A KE3841A KE384188A KE3841A KE 3841 A KE3841 A KE 3841A KE 3841 A KE3841 A KE 3841A KE 384188 A KE384188 A KE 384188A KE 3841 A KE3841 A KE 3841A
Authority
KE
Kenya
Prior art keywords
preparation
compositions containing
antibiotic compound
antibiotic
compound
Prior art date
Application number
KE3841A
Other languages
English (en)
Inventor
Lauri Antero Marvola Martti
Veikko Marttila Esko
Antero Uotila Jaakko
Kyllikki Pippuri Aino
Juhani Kairisalo Pekka
Juhani Honkanen Erkki
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of KE3841A publication Critical patent/KE3841A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
KE3841A 1984-01-06 1988-10-28 An antibiotic compound,a method for its preparation,and compositions containing it KE3841A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (1)

Publication Number Publication Date
KE3841A true KE3841A (en) 1989-04-07

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3841A KE3841A (en) 1984-01-06 1988-10-28 An antibiotic compound,a method for its preparation,and compositions containing it

Country Status (38)

Country Link
US (1) US4599326A (xx)
JP (1) JPS60158197A (xx)
KR (1) KR900006237B1 (xx)
AT (1) AT386414B (xx)
AU (1) AU565688B2 (xx)
BE (1) BE901411A (xx)
BG (1) BG43189A3 (xx)
CA (1) CA1224461A (xx)
CH (1) CH666275A5 (xx)
CS (1) CS247191B2 (xx)
CY (1) CY1462A (xx)
DE (1) DE3500179A1 (xx)
DK (1) DK149776C (xx)
ES (1) ES8605818A1 (xx)
FI (1) FI77249C (xx)
FR (1) FR2557878B1 (xx)
GB (1) GB2152502B (xx)
HK (1) HK11590A (xx)
HU (1) HU196221B (xx)
IE (1) IE57967B1 (xx)
IL (1) IL73885A (xx)
IS (1) IS2968A7 (xx)
IT (1) IT1184304B (xx)
KE (1) KE3841A (xx)
LU (1) LU85721A1 (xx)
MA (1) MA20316A1 (xx)
MX (1) MX156277A (xx)
NL (1) NL8403979A (xx)
NO (1) NO160263C (xx)
NZ (1) NZ210606A (xx)
PH (1) PH22471A (xx)
PL (1) PL144349B1 (xx)
PT (1) PT79777B (xx)
RO (1) RO91262B (xx)
SE (1) SE461854B (xx)
SU (1) SU1410866A3 (xx)
YU (1) YU44485B (xx)
ZA (1) ZA8410143B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
JP4694207B2 (ja) * 2002-07-05 2011-06-08 コルジウム ファーマシューティカル， インコーポレイテッド オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
EP1680083A1 (en) * 2003-10-31 2006-07-19 ALZA Corporation Compositions and dosage forms for ehnanced absorption of iron
ES2653568T3 (es) 2004-06-12 2018-02-07 Collegium Pharmaceutical, Inc. Formulaciones de fármacos para la prevención del abuso
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
EP1789075A4 (en) 2004-08-25 2009-07-01 Uab Research Foundation ABSORPTION ENHANCER FOR DRUG ADMINISTRATION
CA2743725A1 (en) 2006-06-23 2007-12-27 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CN108892709A (zh) 2011-05-18 2018-11-27 欧莫德里斯制药公司 改良的肽药物
EP3444281B1 (en) 2012-11-20 2021-11-03 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
MX360816B (es) 2012-11-20 2018-11-15 Mederis Diabetes Llc Productos farmacéuticos peptídicos mejorados para la resistencia a la insulina.
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
MX371033B (es) 2014-05-28 2020-01-13 Mederis Diabetes Llc Productos farmacéuticos mejorados de péptido para resistencia a la insulina.
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
EP3624840A4 (en) * 2017-05-19 2021-03-10 Lunella Biotech, Inc. ANTIMITOSCINE: TARGETED INHIBITORS OF MITOCHONDRIAL BIOGENESIS TO DESCRIBE CANCER STEM CELLS
US11497759B2 (en) 2017-12-01 2022-11-15 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
WO2019157099A1 (en) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Intranasal epinephrine formulations and methods for the treatment of disease
MX2020008132A (es) 2018-02-06 2020-11-18 Aegis Therapeutics Llc Formulaciones de epinefrina intranasal y metodos para el tratamiento de enfermedades.
JP2022516414A (ja) * 2018-12-17 2022-02-28 ルネラ・バイオテック・インコーポレーテッド ミトコンドリアを標的化し癌幹細胞を死滅させるための三剤併用療法
BR112021011964A2 (pt) * 2018-12-17 2021-09-08 Lunella Biotech, Inc. Terapias de combinação tripla para antienvelhecimento

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
AU565688B2 (en) 1987-09-24
BE901411A (fr) 1985-04-16
SE461854B (sv) 1990-04-02
CY1462A (en) 1989-07-21
DK5884D0 (da) 1984-01-06
FR2557878A1 (fr) 1985-07-12
SE8406671D0 (sv) 1984-12-28
FI77249B (fi) 1988-10-31
KR900006237B1 (ko) 1990-08-27
SE8406671L (sv) 1985-07-07
ES8605818A1 (es) 1986-04-01
CS247191B2 (en) 1986-12-18
CH666275A5 (de) 1988-07-15
MX156277A (es) 1988-08-04
ZA8410143B (en) 1985-08-28
RO91262B (ro) 1987-07-01
RO91262A (ro) 1987-06-30
NO160263B (no) 1988-12-19
DK149776C (da) 1987-04-21
NZ210606A (en) 1987-08-31
DK5884A (da) 1985-07-07
YU44485B (en) 1990-08-31
ES539349A0 (es) 1986-04-01
GB2152502B (en) 1987-10-07
LU85721A1 (fr) 1985-07-24
JPH029040B2 (xx) 1990-02-28
ATA985A (de) 1988-01-15
DK149776B (da) 1986-09-29
SU1410866A3 (ru) 1988-07-15
FI850023A0 (fi) 1985-01-03
IE57967B1 (en) 1993-06-02
GB2152502A (en) 1985-08-07
PT79777B (en) 1986-10-21
US4599326A (en) 1986-07-08
IE850022L (en) 1985-07-06
AU3705984A (en) 1985-07-11
PL251457A1 (en) 1985-11-05
IL73885A0 (en) 1985-03-31
PL144349B1 (en) 1988-05-31
PT79777A (en) 1985-01-01
GB8432368D0 (en) 1985-02-06
NO160263C (no) 1989-03-29
DE3500179A1 (de) 1985-07-18
FI850023L (fi) 1985-07-07
YU2085A (en) 1987-12-31
NO850007L (no) 1985-07-08
FR2557878B1 (fr) 1988-01-15
HU196221B (en) 1988-10-28
PH22471A (en) 1988-09-12
IS2968A7 (is) 1985-04-03
IT1184304B (it) 1987-10-28
JPS60158197A (ja) 1985-08-19
FI77249C (fi) 1989-02-10
IT8519012A0 (it) 1985-01-04
IL73885A (en) 1988-10-31
HK11590A (en) 1990-02-23
KR850005452A (ko) 1985-08-26
CA1224461A (en) 1987-07-21
MA20316A1 (fr) 1985-10-01
DE3500179C2 (xx) 1989-08-24
HUT37628A (en) 1986-01-23
BG43189A3 (en) 1988-04-15
AT386414B (de) 1988-08-25
NL8403979A (nl) 1985-08-01

Similar Documents

Publication Publication Date Title
HK11590A (en) An antibiotic compound,a method for its preparation,and compositions containing it
NZ213463A (en) Antibiotic compound and compositions
AU4893385A (en) Stabilized composition containing inositoltriphosphate
EG17459A (en) Method for preparation 9a-aza-9a-homoerythromycin derivatives
AU4382685A (en) Nylon composition
GB2160771B (en) Composition for oral application
AU566987B2 (en) Antioestrogenic compounds
AU582369B2 (en) Aminophenol compounds
AU572766B2 (en) Filling method
AU583419B2 (en) 2-oxa-isocephem compounds, compositions containing same and processes for preparing same
GB2153358B (en) 1a,25-dihydroxy-22z-dehydrovitamin d2 compound
DE3568977D1 (en) An interphenylene-carbacyclin compound
EG17015A (en) An antibiotic compound a method for its preparation and compositions containing it
GR82519B (en) Antibiotic compound, method for its preparation and composition containing it
DE3262616D1 (en) Beta-lactam derivatives, a process for their preparation and compositions containing them
GB8432519D0 (en) Antibiotic compounds
AU4964085A (en) Kraftpaket for uppvarmning medelst mikrovagsenergi
GB8423278D0 (en) Antibiotic compounds
AU580577B2 (en) Compositions
AU584894B2 (en) Chemical composition
IE842100L (en) Antibiotic compound
IL80107A0 (en) Alkenylazoles,a process for their preparation and compositions containing them
GB8406039D0 (en) Composition method
BG39018A1 (en) Composition for phenoplastics
GB8525335D0 (en) Composition & method